These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 21870361)

  • 1. [Autophagy: a necessary allied in the growth of pancreatic adenocarcinoma].
    Larsen CJ
    Bull Cancer; 2011 Jul; 98(7):719-22. PubMed ID: 21870361
    [No Abstract]   [Full Text] [Related]  

  • 2. UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells.
    Dando I; Fiorini C; Pozza ED; Padroni C; Costanzo C; Palmieri M; Donadelli M
    Biochim Biophys Acta; 2013 Mar; 1833(3):672-9. PubMed ID: 23124112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs.
    Hashimoto D; Bläuer M; Hirota M; Ikonen NH; Sand J; Laukkarinen J
    Eur J Cancer; 2014 May; 50(7):1382-90. PubMed ID: 24503026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine-mediated cell death in metastatic pancreatic adenocarcinoma through inhibition of autophagy.
    Frieboes HB; Huang JS; Yin WC; McNally LR
    JOP; 2014 Mar; 15(2):189-97. PubMed ID: 24618445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
    Lin X; Luo K; Lv Z; Huang J
    Hepatogastroenterology; 2012; 59(114):584-8. PubMed ID: 22353526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy Inhibition in Pancreatic Adenocarcinoma.
    Boone BA; Zeh HJ; Bahary N
    Clin Colorectal Cancer; 2018 Mar; 17(1):25-31. PubMed ID: 29223362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers.
    Gründker C; Ernst J; Reutter MD; Ghadimi BM; Emons G
    Oncol Rep; 2011 Sep; 26(3):629-35. PubMed ID: 21667032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
    Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
    Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
    Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
    Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
    Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy.
    Tonra JR; Deevi DS; Corcoran E; Li H; Wang S; Carrick FE; Hicklin DJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2197-207. PubMed ID: 16609035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
    Duxbury MS; Ito H; Ashley SW; Whang EE
    Biochem Biophys Res Commun; 2004 May; 317(3):837-43. PubMed ID: 15081416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma.
    Yin S; Goodrich DW
    Int J Oncol; 2006 Mar; 28(3):781-5. PubMed ID: 16465385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
    Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
    Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists.
    Brandi J; Dando I; Palmieri M; Donadelli M; Cecconi D
    Electrophoresis; 2013 May; 34(9-10):1359-68. PubMed ID: 23463621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo.
    Suzuki Y; Ohga N; Morishita Y; Hida K; Miyazono K; Watabe T
    J Cell Sci; 2010 May; 123(Pt 10):1684-92. PubMed ID: 20406889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.